Daewoong Pharmaceutical has signed a 33.7 billion won export deal for its diabetes drug Enblo in eight Latin American countries, expanding its global footprint and accelerating portfolio diversification.
#YonhapInfomax #DaewoongPharmaceutical #Enblo #ExportDeal #LatinAmerica #DiabetesMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90787